These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 16453257)

  • 21. Monoclonal antibodies directed against protective antigen of Bacillus anthracis enhance lethal toxin activity in vivo.
    Little SF; Webster WM; Fisher DE
    FEMS Immunol Med Microbiol; 2011 Jun; 62(1):11-22. PubMed ID: 21231965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delayed treatment with W1-mAb, a chimpanzee-derived monoclonal antibody against protective antigen, reduces mortality from challenges with anthrax edema or lethal toxin in rats and with anthrax spores in mice.
    Altaweel L; Chen Z; Moayeri M; Cui X; Li Y; Su J; Fitz Y; Johnson S; Leppla SH; Purcell R; Eichacker PQ
    Crit Care Med; 2011 Jun; 39(6):1439-47. PubMed ID: 21336113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human antibodies from immunized donors are protective against anthrax toxin in vivo.
    Wild MA; Xin H; Maruyama T; Nolan MJ; Calveley PM; Malone JD; Wallace MR; Bowdish KS
    Nat Biotechnol; 2003 Nov; 21(11):1305-6. PubMed ID: 14555959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional analysis of Bacillus anthracis protective antigen by using neutralizing monoclonal antibodies.
    Brossier F; Lévy M; Landier A; Lafaye P; Mock M
    Infect Immun; 2004 Nov; 72(11):6313-7. PubMed ID: 15501759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mouse monoclonal antibodies to anthrax edema factor protect against infection.
    Leysath CE; Chen KH; Moayeri M; Crown D; Fattah R; Chen Z; Das SR; Purcell RH; Leppla SH
    Infect Immun; 2011 Nov; 79(11):4609-16. PubMed ID: 21911463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mapping the epitopes of a neutralizing antibody fragment directed against the lethal factor of Bacillus anthracis and cross-reacting with the homologous edema factor.
    Thullier P; Avril A; Mathieu J; Behrens CK; Pellequer JL; Pelat T
    PLoS One; 2013; 8(5):e65855. PubMed ID: 23741517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The major neutralizing antibody responses to recombinant anthrax lethal and edema factors are directed to non-cross-reactive epitopes.
    Nguyen ML; Terzyan S; Ballard JD; James JA; Farris AD
    Infect Immun; 2009 Nov; 77(11):4714-23. PubMed ID: 19720758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a novel multiepitope chimeric vaccine against anthrax.
    Aggarwal S; Somani VK; Gupta S; Garg R; Bhatnagar R
    Med Microbiol Immunol; 2019 Apr; 208(2):185-195. PubMed ID: 30671633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stochastic humoral immunity to Bacillus anthracis protective antigen: identification of anti-peptide IgG correlating with seroconversion to Lethal Toxin neutralization.
    Dumas EK; Nguyen ML; Cox PM; Rodgers H; Peterson JL; James JA; Farris AD
    Vaccine; 2013 Apr; 31(14):1856-63. PubMed ID: 23415781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and characterization of immunodominant B-cell epitope of the C-terminus of protective antigen of Bacillus anthracis.
    Kaur M; Chug H; Singh H; Chandra S; Mishra M; Sharma M; Bhatnagar R
    Mol Immunol; 2009 Jun; 46(10):2107-15. PubMed ID: 19356802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selection and evaluation of the immunogenicity of protective antigen mutants as anthrax vaccine candidates.
    Yan M; Roehrl MH; Basar E; Wang JY
    Vaccine; 2008 Feb; 26(7):947-55. PubMed ID: 18192092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anthrax toxin receptor 2-dependent lethal toxin killing in vivo.
    Scobie HM; Wigelsworth DJ; Marlett JM; Thomas D; Rainey GJ; Lacy DB; Manchester M; Collier RJ; Young JA
    PLoS Pathog; 2006 Oct; 2(10):e111. PubMed ID: 17054395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The 2beta2-2beta3 loop of anthrax protective antigen contains a dominant neutralizing epitope.
    Zhang J; Xu J; Li G; Dong D; Song X; Guo Q; Zhao J; Fu L; Chen W
    Biochem Biophys Res Commun; 2006 Mar; 341(4):1164-71. PubMed ID: 16460675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of anthrax lethal toxin cytotoxicity: a subset of monoclonal antibodies against protective antigen increases lethal toxin-mediated killing of murine macrophages.
    Mohamed N; Li J; Ferreira CS; Little SF; Friedlander AM; Spitalny GL; Casey LS
    Infect Immun; 2004 Jun; 72(6):3276-83. PubMed ID: 15155630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lethal factor antibodies contribute to lethal toxin neutralization in recipients of anthrax vaccine precipitated.
    Dumas EK; Garman L; Cuthbertson H; Charlton S; Hallis B; Engler RJM; Choudhari S; Picking WD; James JA; Farris AD
    Vaccine; 2017 Jun; 35(26):3416-3422. PubMed ID: 28504191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Toxin-neutralizing monoclonal antibodies to the different domains of anthrax protective antigen].
    Xu JJ; Zhang J; Liu SL; Lv TJ; Chen W; Li GL; Ge M; Guo Q
    Wei Sheng Wu Xue Bao; 2005 Dec; 45(6):947-51. PubMed ID: 16496709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neutralizing monoclonal antibody to edema toxin and its effect on murine anthrax.
    Winterroth L; Rivera J; Nakouzi AS; Dadachova E; Casadevall A
    Infect Immun; 2010 Jun; 78(6):2890-8. PubMed ID: 20385755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combining anthrax vaccine and therapy: a dominant-negative inhibitor of anthrax toxin is also a potent and safe immunogen for vaccines.
    Aulinger BA; Roehrl MH; Mekalanos JJ; Collier RJ; Wang JY
    Infect Immun; 2005 Jun; 73(6):3408-14. PubMed ID: 15908368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A soluble receptor decoy protects rats against anthrax lethal toxin challenge.
    Scobie HM; Thomas D; Marlett JM; Destito G; Wigelsworth DJ; Collier RJ; Young JA; Manchester M
    J Infect Dis; 2005 Sep; 192(6):1047-51. PubMed ID: 16107958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a receptor-based inhibitory penta-unit-conjugated peptide to enhance anthrax toxin neutralization.
    Lee SC; Yoon MY
    Int J Biol Macromol; 2020 Nov; 163():327-335. PubMed ID: 32619663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.